Wordt geladen...
Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
This study investigated the maximum tolerated dose (MTD) of S-1 with concurrent radiotherapy in patients with head and neck cancer, based on the frequency of dose-limiting toxicities (DLT). S-1 was administered orally at escalating doses from 40 mg/m(2) b.i.d. on the days of delivering radiotherapy,...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3709662/ https://ncbi.nlm.nih.gov/pubmed/23292146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrs133 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|